Advertisement

Topics

Iovance to add patients to melanoma study

05:56 EDT 12 Oct 2018 | SmartBrief

Iovance Biotherapeutics intends to enroll a cohort of 80 to 100 patients to its ongoing midstage study of LN-144-01 for melan -More

Original Article: Iovance to add patients to melanoma study

NEXT ARTICLE

More From BioPortfolio on "Iovance to add patients to melanoma study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...